-
Mashup Score: 4Test May Show Whether to Treat Prostate Cancer with Hormones - 11 month(s) ago
For some men with prostate cancer, a genetic biomarker test called Decipher may help predict whether the cancer will spread to other parts of the body. The test could help determine whether hormone therapy, which can cause distressing side effects, is needed.
Source: National Cancer InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 12NF1 Associated with More Cancer Types Than Previously Known - 12 month(s) ago
People with neurofibromatosis type 1 (NF1) develop more types of cancer than previously recognized, according to a new study. They also developed some cancers at an earlier age and were more likely to die from several cancer types, compared with the general population. The findings emphasize the importance of preventive measures and early diagnosis for people with NF1.
Source: National Cancer InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 9Update Your Browser | Facebook - 1 year(s) ago
Get Facebook on Your PhoneStay connected anytime, anywhere.
Source: instagram.comCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 3Parent Concerns About HPV Vaccine Safety Increasing - 2 year(s) ago
Despite more than 15 years of consistent evidence that HPV vaccines are safe and effective, a new study shows that more parents are now citing concerns about the vaccines’ safety. The findings highlight an urgent need for doctors and public health leaders to address these concerns with parents, study researchers said.
Source: National Cancer InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 8
Certain gut microbes can help the immune system fight tumors — and CCR scientists have figured out one way they do it. In experiments reported Oct.
Source: ccr.cancer.govCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1NIH study illuminates lung cancer origins in never smokers - 2 year(s) ago
NCI scientists and their international collaborators have found that the majority of lung cancers in never smokers arise when mutations caused by natural processes in the body accumulate. They also identified three subtypes of lung cancer in these individuals. These insights may lead to more precise treatments.
Source: National Cancer InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 8Breast Cancer Surgery’s Impact on Quality of Life - 2 year(s) ago
Women with early-stage breast cancer who had one or both breasts surgically removed (a unilateral or bilateral mastectomy) had lower scores on a quality-of-life survey than women who had breast-conserving surgery, a new study has found. The survey questions include those about psychosocial and sexual well-being.
Source: National Cancer InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Study Examines Whether Blood Test Can Identify Early Cancers - 2 year(s) ago
A blood test combined with imaging tests detected tumors—some at an early stage—in women without a history of cancer or any symptoms, a recent study showed. The liquid biopsy, called CancerSEEK, also mistakenly indicated some women had cancer when additional testing determined they did not.
Source: National Cancer InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 6Report Details Alcohol’s Global Cancer Burden - 3 year(s) ago
Nearly 750,000 cases of cancer diagnosed worldwide in 2020, or 4%, can be attributed to alcohol consumption, according to a new World Health Organization (WHO) study. While heavy drinking accounted for the most cases, light and moderate drinking accounted for more than 100,000 of those cases.
Source: National Cancer InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 8PSMA Radiopharmaceutical Effective against Prostate Cancer - 3 year(s) ago
A drug called 177Lu-PSMA-617 may be a new option for treating advanced prostate cancer. In a large clinical trial called VISION, participants who received 177Lu-PSMA-617—a type of drug called a radiopharmaceutical—along with standard treatments lived longer than those who received only standard therapies.
Source: National Cancer InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
In 2021, a large study confirmed that a genetic test may correctly predict how likely it is for recurrent #ProstateCancer to spread to other parts of the body. https://t.co/k315pDjUqu #MensHealthMonth #repost